Technical Analysis for REVB - Revelation Biosciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Slingshot Bearish | Bearish Swing Setup | 0.00% | |
Bullish Engulfing | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 16.97% | |
New 52 Week Low | Weakness | 16.97% | |
Wide Bands | Range Expansion | 16.97% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | 2 days ago |
Up 3% | 2 days ago |
Up 2% | 2 days ago |
Up 1% | 2 days ago |
Down 3% | 3 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/20/2024
Revelation Biosciences, Inc. Description
Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. In addition to Revelation’s therapeutic pipeline, Revelation is also developing REVDx-501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Disease Immunology Infection Vaccination Respiratory Diseases Allergology Nasal Administration Rhinitis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 35.4 |
52 Week Low | 1.61 |
Average Volume | 49,496 |
200-Day Moving Average | 11.68 |
50-Day Moving Average | 2.19 |
20-Day Moving Average | 1.99 |
10-Day Moving Average | 1.87 |
Average True Range | 0.19 |
RSI (14) | 46.24 |
ADX | 12.43 |
+DI | 21.41 |
-DI | 23.37 |
Chandelier Exit (Long, 3 ATRs) | 1.93 |
Chandelier Exit (Short, 3 ATRs) | 2.17 |
Upper Bollinger Bands | 2.42 |
Lower Bollinger Band | 1.56 |
Percent B (%b) | 0.43 |
BandWidth | 42.92 |
MACD Line | -0.14 |
MACD Signal Line | -0.14 |
MACD Histogram | 0.0003 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.38 | ||||
Resistance 3 (R3) | 2.34 | 2.14 | 2.31 | ||
Resistance 2 (R2) | 2.14 | 2.03 | 2.17 | 2.28 | |
Resistance 1 (R1) | 2.04 | 1.96 | 2.09 | 2.08 | 2.25 |
Pivot Point | 1.84 | 1.84 | 1.87 | 1.87 | 1.84 |
Support 1 (S1) | 1.74 | 1.73 | 1.79 | 1.78 | 1.61 |
Support 2 (S2) | 1.54 | 1.66 | 1.57 | 1.58 | |
Support 3 (S3) | 1.44 | 1.54 | 1.56 | ||
Support 4 (S4) | 1.48 |